Scientists hunt for blood cancer clues in patient samples
NCT ID NCT00923442
First seen Jun 26, 2026 · Last updated Jul 17, 2026 · Updated 2 times
Summary
This study collects blood and bone marrow samples from up to 550 people with blood cancers like leukemia, lymphoma, and myelodysplastic syndrome. Researchers will study the cells, genes, and proteins in these samples to better understand how these cancers develop and to find new targets for treatments. No experimental therapies are given; the goal is purely to gather knowledge that may lead to future advances.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this research could point toward new treatments or vaccines for blood cancers by revealing how these cancers work at a cellular and genetic level.
- What could go wrong
- This is an observational study, not a treatment trial. It collects samples for lab research, so there is no direct benefit to participants. The findings may not lead to new therapies for many years, if at all.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOBLASTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can specially trained immune cells flush out hidden HIV?
- Can a Low-Dose antifungal shield vulnerable patients from deadly fungal infections?
- Can a gentler chemo prep make stem cell transplants safer for blood cancer patients?
- Frailty check may steer safer cancer care for seniors
- A simple blood test may reveal hidden infertility risk in young cancer survivors
- Can a smart tool keep watch on leukemia after treatment stops?